These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38768417)

  • 41. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integration of Continuous Glucose Monitoring Data into an Electronic Health Record System: Single-Center Implementation.
    Aleppo G; Chmiel R; Zurn A; Bandoske R; Creamer P; Neubauer N; Wong J; Andrade SB; Hauptman A
    J Diabetes Sci Technol; 2023 Aug; ():19322968231196168. PubMed ID: 37644816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
    Pettus J; Edelman SV
    J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinically Similar Clusters of Daily Continuous Glucose Monitoring Profiles: Tracking the Progression of Glycemic Control Over Time.
    Kovatchev B; Lobo B
    Diabetes Technol Ther; 2023 Aug; 25(8):519-528. PubMed ID: 37130300
    [No Abstract]   [Full Text] [Related]  

  • 45. An Observational Crossover Study of People Using Real-Time Continuous Glucose Monitors Versus Self-Monitoring of Blood Glucose: Real-World Evidence Using EMR Data From More Than 12,000 People With Type 1 Diabetes.
    Noor N; Norman G; Sonabend R; Chao L; Kamboj M; Golden L; Bekx MT; Hseih S; Levy C; Sanchez J; Rapaport R; Ebekozien O
    J Diabetes Sci Technol; 2023 Jun; ():19322968231178017. PubMed ID: 37264642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
    Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
    Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
    Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
    Ruedy KJ; Parkin CG; Riddlesworth TD; Graham C;
    J Diabetes Sci Technol; 2017 Nov; 11(6):1138-1146. PubMed ID: 28449590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
    Gilbert TR; Noar A; Blalock O; Polonsky WH
    Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Jensen MH; Vestergaard P; Hirsch IB; Hejlesen O
    J Diabetes Sci Technol; 2022 Jan; 16(1):106-112. PubMed ID: 32945187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterizing blood glucose variability using new metrics with continuous glucose monitoring data.
    Marling CR; Shubrook JH; Vernier SJ; Wiley MT; Schwartz FL
    J Diabetes Sci Technol; 2011 Jul; 5(4):871-8. PubMed ID: 21880228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of do-it-yourself real-time continuous glucose monitoring on psychological and glycemic variables in children with type 1 diabetes: A randomized crossover trial.
    Elbalshy MM; Styles S; Haszard JJ; Galland BC; Crocket H; Jefferies C; Wiltshire E; Tomlinson P; de Bock MI; Wheeler BJ
    Pediatr Diabetes; 2022 Jun; 23(4):480-488. PubMed ID: 35253331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes.
    Dunn TC; Ajjan RA; Bergenstal RM; Xu Y
    Diabetes Technol Ther; 2024 Mar; 26(3):203-210. PubMed ID: 38444315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tolerability and acceptability of real-time continuous glucose monitoring and its impact on diabetes management behaviours in individuals with Type 2 Diabetes - A pilot study.
    Taylor PJ; Thompson CH; Luscombe-Marsh ND; Wycherley TP; Wittert G; Brinkworth GD; Zajac I
    Diabetes Res Clin Pract; 2019 Sep; 155():107814. PubMed ID: 31421138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of structured Ramadan Nutrition Plan on glycemic control and variability using continuous glucose monitoring in individuals with type 2 diabetes: A pilot study.
    Hasbullah FY; Mohd Yusof BN; Wan Zukiman WZHH; Abu Zaid Z; Omar N; Liu RXY; Marczewska A; Hamdy O
    Diabetes Metab Syndr; 2022 Oct; 16(10):102617. PubMed ID: 36174477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial.
    Polonsky WH; Hessler D; Ruedy KJ; Beck RW;
    Diabetes Care; 2017 Jun; 40(6):736-741. PubMed ID: 28389582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles.
    Tweden KS; Deiss D; Rastogi R; Addaguduru S; Kaufman FR
    Diabetes Technol Ther; 2020 May; 22(5):422-427. PubMed ID: 31697182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
    Rodbard D
    Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.